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Abstract 
Objective: Antibiotics can be prescribed as prophylaxis against surgical site infection (SSI) in 
dermatological surgery. In accordance with antibiotic stewardship, clinical evidence should 
inform judicious antibiotic prescribing. This review aimed to identify patient and procedure 
related risk factors for SSI following minor dermatological surgery.  
Data sources: MEDLINE, CINAHL, Informit and Scopus databases were searched for relevant 
literature on patient populations receiving minor surgery, where risk factors for SSI were 
explicitly stated. 
Study Selection: Studies involving major dermatological surgery were excluded.  The 
preliminary search yielded 820 studies after removing duplicates. 210 abstracts were screened, 
and 42 full texts were assessed for eligibility. A total of 13 papers were included. Studies were 
appraised using the Newcastle-Ottawa Quality Assessment Scale.  
Data Extraction: An electronic data collection tool was constructed to extract information from 
the eligible studies, and distributed to participating authors.  
Data synthesis: Risk factors identified included age, sex, diabetes mellitus, chronic obstructive 
pulmonary disease (COPD), anti-hypertensive and corticosteroid use, smoking, surgery on the 
lower or upper extremities, excision of non-melanocytic skin cancers (NMSC), large skin 
excisions and complex surgical techniques. A maximum of two studies agreed on any one risk 
factor and there were insufficient studies for meta-analysis.  
Conclusions: Re-excision of skin cancer, below knee excisions and intra-operative 
haemorrhagic complications were predictive for infection in more than one study. More high-




Surgical site infection (SSI) following dermatological surgery is associated with prolonged 
wound healing, lengthened recovery time, poor cosmesis and overall increased costs to the 
health system.1 Both patient and clinician concerns regarding these adverse outcomes result in 
an anticipatory safety net of inappropriate antibiotic prophylaxis, which promotes undesirable 
antibiotic resistance.2 A key recommendation from the antibiotic stewardship guidelines from 
the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of 
America is that antibiotic therapy should be based on patient specific factors,3 hence an 
awareness of patients who are at higher risk of SSI is necessary to encourage more judicious 
antibiotic prescribing. 
To accurately define patient groups predisposed to developing a SSI, a comprehensive 
understanding of patient, procedural and physician related risk factors is necessary. Extensive 
clinical studies have investigated these risk factors in small to large cohorts, however to our 
knowledge few studies have presented a large systematic review of all possible risk factors 
which contribute to an individual’s overall risk of infection.  
This review aims to systematically appraise the current evidence of risk factors for SSI in minor 
dermatological surgery, and identify where further research may be required.  
Methods  
Protocol/registration 
The systematic review was registered in the PROSPERO international prospective register of 
systematic reviews (ID CRD42016045830).  
Eligibility criteria 
Two eligibility criteria were applied in this review. The first was based on a population, 
intervention, comparison and outcome (PICO) strategy (Table 1). Eligible papers examined 
populations of patients undergoing minor dermatological surgical procedures (from 1990 to 
date), and described relevant risk factors for SSI in sufficient detail for data extraction. Minor 
dermatological surgery was defined as any small surgical procedure carried out on the skin, in 
an outpatient setting. The definition did not account for the size of the lesion excised.  Although 
skin flaps could be considered to be a more complex surgery, they were included as they are 
often carried out in a primary care outpatient setting in Australia. Graft and Mohs procedures 
were included if they were a component of a study which included simple skin excisions but 
data on individual procedures could not be extracted. Major surgeries (which were excluded) 
were defined as larger plastic surgery procedures such as mammoplasties, abdominoplasties 
and gluteoplasties, as well as burns, graft procedures, and major oncological surgeries 
involving structures other than the skin (e.g. removal of head and neck cancer).  
[TABLE 1] 
The second eligibility criteria regarded the study design. Only cohort or case control studies in 
the English language were eligible for inclusion. Interventional studies, case studies, 
commentaries, letters, editorials and reviews were excluded. Randomised controlled trials were 
only included when the authors performed a secondary data analysis to define risk factors for 
surgical site infection.  
Information sources 
Ovid MEDLINE, CINAHL, Scopus and Informit were searched to identify relevant literature, 
from January 1, 1990 to the date of search. The search was conducted in May 2016, and 
repeated in August 2017. Reference lists of identified papers were also searched for additional 
studies.  
Search 
A search strategy based on the ‘PICO’ format described in Table 1 was employed, using the 
search terms “Dermatological surgical procedures”, “minor surgical procedures”, “surgical 
wound infection”, “skin neoplasms”, “plastic surgery”, and variations (as suggested by the 
MESH headings), combined with Boolean search terms ‘AND’ and ‘OR’ as appropriate. 
Specifiers within each term’s subject tree were used to narrow down the search. The MESH 
terms and their alternative terms were used in databases which could not be searched using 
subject headings. Full electronic search strategies for each database can be found in the 
appendix.  
Study selection 
Following removal of duplicates, title scanning for relevance resulted in removal of a number 
of papers from consideration, while titles that were ambiguous were included for abstract 
screening. The remaining abstracts were then perused to identify articles relevant to the topic, 
followed by full text screening, using the PICO criteria described in Table 1. The author (MD) 
and two independent assessors (MP and PD) screened all papers.  
Data collection process  
A data collection tool was constructed to extract information from the eligible studies. This 
tool comprised the following fields: ‘author’, ‘year’, ‘country’, ‘study type’, ‘population’, 
‘setting’, ‘sample size’, ‘methods used’, ‘surgical procedures done’, ‘definition of infection’, 
‘infections’, ‘risk factors for infection’, ‘secondary outcomes’, ‘key conclusions’ and ‘source 
of funding’. Infections were expressed as absolute and relative frequencies.  
Risk of bias in individual studies  
Papers were evaluated with the Newcastle-Ottawa Quality Assessment Scales to determine the 
quality of each study. Papers found to be of low quality were interpreted with caution.  
Summary measures 
The ideal summary measure for this review was relative risk. If relative risk was not available, 
then odds ratios were presented. If neither were available, proportions of infection in each risk 
factor group were presented, with confidence intervals and statistical significance if available.   
Synthesis of results  
The risk factors identified were highly variable and expressed via different summary measures, 
therefore a meta-analysis was not performed due to the heterogeneity of the data.  
Results  
Study selection 
The literature search retrieved 892 articles. Following elimination of 72 duplicates, 610 articles 
were excluded after title screening. Abstracts of the remaining 210 eligible articles were 
reviewed, and 42 full texts were screened. A total of 13 studies were included. This screening 
process is presented in the context of the ‘Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses’ (PRISMA) flow chart, in Fig. 1.  
Figure 1. Screening process of eligible articles as per the PRISMA guidelines. 
[FIG 1 HERE] 
Characteristics  
Study characteristics and results of individual studies have been combined into one single 
section below.  
Risk of bias within studies 
The quality of the studies per the ‘Newcastle-Ottawa Quality Assessment’ is presented in Table 
2. Only one quality assessment scale was required. Most studies were representative of the 
‘true exposed cohort’, as they followed all patients from the start of the study until its endpoint, 
and only excluded patients if they significantly altered the results (i.e. already taking 
antibiotics). The main source of bias arose from assessment of the primary outcome. The 
diagnosis of surgical site infection is subjective, and while several different definitions exist, 
there is a need for more validated, reliable and standardised definition of SSI.4 We decided to 
employ the Centres for Disease Control (CDC) criteria as it is currently considered to be the 
gold standard, although is still prone to subjectivity.5 The time period involved for definition 
of infection varied between studies from time of discharge from hospital, to time of removal 
of sutures or 30 days post-operatively (The CDC guidelines use up to 30 days). Further, in all 
but one study the outcomes were self-reported either by the investigators or a separate clinician. 
The study which did not self-report outcomes enlisted a pathologist to blindly report whether 
infection was present or not in lab results.6  
Results of individual studies 
Results of individual studies are summarised in Table 3. Two of the 14 studies were performed 
in a general practice setting,7-8 with the remainder in private clinic rooms, operating theatres or 
a combination. Studies were based in Australia, North America or Europe. Two studies 
consisted of total procedures rather than total patients, which raised the issue of having multiple 
wounds per patient. These studies are marked accordingly in Table 3. Infection rates ranged 
from 1.3%-27.0%, however the overall incidence of infection was low. Exceptions were studies 
carried out in general practice settings in Australia, and another study with a small sample 
size.7-9 Demographic, social/environmental, medical, preoperative and intraoperative risk 
factors were described in the studies. Only two papers reported their results with a relative risk. 
Due to non-homogeneity of results across the papers identified, the risk information was 
collectively presented under the column ‘Risk measure’, as either relative risk, odds ratio, 
proportion of the exposure group that developed the outcome versus the proportion without.  
[TABLE 2 HERE] 
[TABLE 3 HERE] 
Demographic factors  
Only one study of 1000 patients reported older age (>50 years) as a risk factor (OR 5.5, 95% 
CI 1.9-16.0).10 Men had a higher risk of infection than women in the same study (OR 5.1, 95% 
CI 1.7-15.9) and in another large prospective study when reconstructive procedures were 
involved (OR 5.46, 95% CI 1.12-26.54, p=0.04).10,11  
Patient medical comorbidities   
A large hospital study found diabetes mellitus (OR 2.54, 95% CI 1.10-5.87, p=0.03) and 
chronic obstructive pulmonary disease (COPD) (OR 2.52, 95% CI 1.06-5.97, p=0.04) were 
significantly associated with infection.12 A smaller general practice study in Australia also 
found that diabetes mellitus predisposed to infection (RR 1.7, 95% CI 1.4-2.2, p<0.001).7  
Medication/treatment related factors 
Use of anti-hypertensives were associated with infection (OR 2.5, 95% CI 1.4-4.2, p-0.006) in 
a large Australian study. A small British study (with a high infection rate) found 63% of 
patients on corticosteroids developed an infection compared to 21% who were not taking the 
medication (95% CI difference 19%-66%, p<0.001).9  
Smoking  
Ex-smokers were found to have a higher risk of infection in a general practice setting (RR 1.7, 
95% CI 1.1-2.6, p=0.02).8 In a small prospective hospital study, 63% of smokers developed an 
infection compared to 12% of non-smokers (95% CI difference 34%-70%, p<0.001).9  
Location of lesion and surgical site  
Procedures below the waist were associated with an increased risk of surgical site infection. In 
one study 48% of patients who had a ‘below waist’ procedure developed an infection, 
compared to 23% in those who received their procedure above the waist (95% CI difference 
4%-47%).9 Another study also reported that 17.6% of their total excisions occurred on the 
lower limb (p<0.001).13 In general practice, there was a higher risk of infection in procedures 
on the thighs (RR 2.2, 95% CI 1.3-3.6, p=0.002) and legs/feet (RR 1.9, 95% CI 1.1-3.1, p=0.02) 
in one study,7 and ‘lower extremities’ (RR 3.7, 95% CI 1.9-6.9, p<0.001) in the other.8 A 
private hospital study reported similar findings, as 6.92% of their surgical wounds below the 
knee (p<0.001), and 10% around the groin (p=0.03) became infected.14 An American study 
supported these findings, with procedures on the leg having increased odds of infection (OR 
4.28, p=0.03).6  
The trunk (OR 4.49, p=0.005), scalp (OR 4.33, p=0.01),6 and upper extremities (RR 3.2, 95% 
CI 2.3-4.4, p<0.001) were high risk surgical sites for infection.8 A smaller study also found 
6.5% of patients receiving surgery on the nose and 5.2% on the ear developed an infection, 
with no statistical inference.  
Surgical factors – complexity and size of procedure 
The type of procedure was reported to be a significant risk factor. In a private surgery setting, 
8.57% of patients receiving wedge resections (lip/ear), and 8.7% of patients receiving graft 
procedures developed an infection (p<0.001).14 Flap repairs had the highest proportion of 
infections (15.5%, p<0.001) in another private surgery based study in Australia.13 This finding 
was supported by a small German study (p=0.009), however this result was not quantified.15 
‘Complex surgical wounds’ (flap and graft procedures) were also risk factors for infection in a 
British study.16  
The same study found excisions larger than 20mm in length conferred an increased risk of 
infection (RR 2.4, 95% CI 1.7-3.4, p<0.001). In a small study of 100 patients, 7.5% of patients 
who had an excision larger than the median defect length (>30mm) developed an infection, 
compared to 1.4% in the group without this exposure.   
Histology of lesion  
Excision of non-melanocytic skin cancers (NMSC), specifically squamous cell carcinomas 
(SCC) and basal cell carcinomas (BCC) were risk factors. This finding was demonstrated in 
general practice, with the earlier study reporting a higher risk of infection if a BCC (RR 2.1, 
95% CI 1.3-3.4, p=0.004) or SCC (RR 1.8, 95% CI 1.3-2.6, p<0.001) was excised.7 The more 
recent study found that conversely, SCC excisions (RR 2.3, 95% CI 1.1-4.6) held a higher risk 
of infection compared to BCC excision (RR 2.1, 95% CI 1.4-3.2, p=0.001), both posing a 
significant risk compared to those who were not having a NMSC excised.8 Another study 
reported a 12.0% infection rate in a population undergoing skin cancer removal, compared to 
0.8% in those that underwent non-cancerous procedures.16 Re-excision of skin cancer was also 
strongly predictive of infection (RR 14.8, 95% CI 4.5-28.5, p<0.001).8 
Haemorrhagic and anaesthetic complications 
A haemorrhagic complication was uncontrolled bleeding around the time of surgery or 
development of a haematoma shortly after, and an anaesthetic complication was vaso-vagal 
syncope, clinical signs of drug reaction or neurological signs of overdose. One study found 
both haemorrhagic (OR 7.59, 95% 3.95-14.61, p<0.001) and anaesthetic complications (OR 
4.58, 95% CI 1.61-13.00, p<0.004) had increased odds of infection.17 Another study carried 
out separate analyses for reconstructive procedures and simple excisions, and haemorrhagic 
complication was a risk factor for infection in both (OR 11.29, 95% CI 3.43-37.16, p<0.001), 
(OR 6.6, 95% CI 2.52-17.30. p<0.001).11  
Other  
Receiving preoperative radiotherapy (OR 20.35, 95% CI 5.37-77.17, p<0.001) and the 
insertion of a surgical drain (OR 3.02, 95% CI 1.64-5.57, p<0.001) were associated with 
increased odds of developing an infection in one Italian study.12 In an audit paper, 28.5% of 
patients whose surgery involved the cartilage developed an infection, compared to 5.9% of the 
group where the surgery was above the level of the cartilage. Mohs surgery on the ear was also 
a risk factor, (12.5% vs.1.45% in the ‘non-ear’ group).18 One of the studies carried out in a 
private surgical setting in Australia found ulceration of the wound/lesion was a risk factor (OR 
3.15, 95% CI 1.8-5.7, p=0.008), as was keeping the wound dry (OR 2.1, 95% CI 1.1-3.8, p-
0.018).13 A small British study reported that location of the operation (53% infected in ward 
vs. 17% in operating theatre, 95% CI difference 17%-55%, p<0.001), and experience of the 
surgeon were associated with infection (33% infected in patients operated on by senior house 
officer, and 14% operated on by a specialist registrar and consultant (95% CI difference 2%-
37%, p=0.03).9   
Aseptic technique  
The use of non-sterile gloves was identified as a risk factor for infection (OR 0.18, 95% CI 
0.05-0.65, p=0.009), in a French study with the odds ratio in favour of sterile gloves, but only 
in a subgroup of more complex procedures.11 
  
Discussion  
This systematic review identified 13 papers which measured risk factors for SSI in 
minor dermatological surgery. Two studies were assessed to be high quality, two were 
moderate-high, two moderate, four low-moderate and three studies were of low-quality.  
Although setting of the studies varied from outpatient clinics/examination rooms to 
hospital operating theatres, it is difficult to assess whether this had an impact, as heterogeneity 
did not allow us to analyse infection by setting. The one study which formally assessed this 
was underpowered and of poor quality.9           
Whilst no restrictions were placed on the country of origin, all included papers were 
published in developed western countries. Surgical site infection is low after dermatological 
surgery as evidenced in this review, and associated with low rates of morbidity and mortality. 
Indeed, the applications of this study are more concerned with improving outcomes relevant in 
western setting, such as costs to the health system, maintaining cosmetic appearance and 
antibiotic resistance. Such issues are minor in comparison to the more pressing public health 
concerns in developing countries.  
Infection rates in most studies were between 1%-5%, consistent with the CDC accepted 
rate of infection following clean minor surgery (<5%).19 Exceptions were three Australian 
studies, conducted in a tropical setting, reporting infection rates between 7.25%-8.70%.  
Only one study identified age>50 as a risk factor on multivariate analysis, however a 
direct relationship is unlikely due to the number of confounding factors associated with older 
age which might lead to vascular compromise, poorer wound healing and greater risk of 
infection. Male sex was a risk factor in two low-moderate quality studies with large sample 
sizes.10,11 This relationship has been identified in non-dermatological studies,20 and is likely 
due to inherent health behaviours and practices of males regarding wound care and post-
surgical management.  
While two large studies demonstrated that Diabetes mellitus was a risk factor, the 
authors of the latter study confirmed that this parameter was under recorded.7,12 Diabetes 
mellitus may be associated with infection due to its immunological and vascular 
complications.21 However, the sparsity and poor level of evidence across the dermatological 
literature makes it difficult to draw any definite conclusions in this population. COPD is a 
plausible risk factor as affected patients have impaired innate immunity.22 It is also possible 
that COPD is associated with infection due to the inherent risks of smoking (see below) and 
concomitant steroid use. 
 Anti-hypertensive and corticosteroid use were risk also factors. The 
immunosuppressive effects of corticosteroid use are well recognised in the medical literature; 
why anti-hypertensive medication predisposes to wound infection is less clear. As the authors 
of this study did not control for medical-comorbidities it is possible that underlying vascular 
defects (causing hypertension) were responsible for impaired wound healing.  Hypertension 
itself (rather than the use of anti-hypertensives) has been purported as a risk factor in non-
dermatological surgery populations.23 
The effect of smoking on SSI is contentious. While generally believed to be a 
contributor to infection due to its adverse effects on perfusion, coagulation, capillary oxygen 
transfer and collagenesis,24 only two studies reported an association. One study had poor 
methodology, and the other claimed that the status of ‘ex-smoker’ rather than ‘current-smoker’ 
conferred an increased risk. This result should be appreciated with caution however, as time 
between quitting smoking and involvement in the study was not specified and it is unclear how 
having previously smoked would impart a greater risk of infection than being a current smoker. 
Several studies identified an increased incidence of infection when procedures were 
performed on the extremities of the upper and lower limbs but particularly below the knee. 
Procedures on the ear and nose were also more likely to become infected.  Although facial 
wounds have a lower infection rate due to high vascularity,16 sites such as the ear and nose 
have been previously noted as high risk areas for infection, due to increased moisture and 
higher concentrations of local flora and sebaceous glands.25 It is likely that the higher risk of 
infection in the extremities is also due to the reduced perfusion at these locations, implying a 
substandard healing process compared to a wound with ample perfusion.  
The impact of the type of the procedure was similarly well documented. The high rates 
of infection after flap and graft procedures are plausible due to the degree of skin damage 
inflicted. Flap surgery is a larger and more complex procedure compared to a simple skin 
incision, and although designed to reduce wound tension, still has a higher overall tension 
compared to smaller closures, deeming it more susceptible to breakage and opening.26 Skin 
grafts are required for wounds too large to be closed by simple techniques, however unlike flap 
surgery, grafted skin lacks adequate blood supply. We postulate that with more complex wound 
closure and compromised blood flow, comes higher risk of wound reopening and poor vascular 
access, creating a portal for infection as well as an ideal environment for bacterial growth. This 
may clarify why wound size was also a significant risk factor for infection.  
Excision of SCCs and BCCs were risk factors for infection in several studies.7,8,16 As 
non-melanocytic skin cancers are often excised from the nose and ear,27 it is possible that it is 
the location on which non-melanocytic skin cancers arise that have a higher risk of developing 
wound infection, rather than the lesion itself. However, BCC and SCC were still a risk factor 
when body site was controlled on multivariate analysis, and it is likely that oncological surgery 
is itself a risk factor, possibly because of the increased risk of ulceration and the viability of 
surrounding skin.   
Haemorrhagic complications were associated with developing an infection in two 
studies, as was an anaesthetic complication. Haemorrhagic complications during surgery might 
indicate a deeper underlying pathology causing abnormal bleeding, and this may be the indirect 
cause of increased risk. Haemostasis comprises the first of the four stages of wound healing,28 
– without this crucial step, the remaining components of tissue repair cannot take place, or 
occur improperly which ultimately results in impaired wound healing. Failure to execute a 
normal inflammatory response followed by rapid tissue remodelling following a surgical injury 
could therefore provide ideal environmental conditions for bacterial colonisation and 
subsequent SSI. Why anaesthetic complications increase infection risk is unclear, but could be 
due to changes in surgical procedure that may occur, favouring resuscitative/supportive action 
over asepsis in such a situation. However, such risk factors are not relevant in the outpatient 
setting in which minor dermatological surgery is typically performed.   
This review had several limitations. Wound infection is a subjective diagnosis and 
subject to intra- and inter-observer variability.29 Standardised diagnostic criteria exist,5 
however many studies did not use them. Secondly, few studies examined the same risk factors. 
This also meant that a meta-analysis was not possible due to the heterogeneity of the data 
collected. Ideally we would have preferred to study more risk factors pertaining to the patient 
and staff, pre-operative skin preparation and other intra-operative variables, however we were 
limited by the variables presented in the studies collected. Lastly, although we limited this 
review to English language, including non-English language articles would have only increased 
findings by one.  
  
Conclusion  
 Identifying risk factors for surgical site infection guides evidence based, judicious 
antibiotic prophylaxis. This systematic review aimed to comprehensively present the current 
known risk factors for SSI following minor dermatological surgery.  
 The risk factors identified were re-excision of skin cancer, below knee excisions, lesion 
histology, developing a haemorrhagic complication during surgery and receiving preoperative 
radiotherapy, however the latter two of these risk factors may not be relevant to the outpatient 
setting in which most minor dermatological surgery is performed.  
 The results of this review study highlight the contribution of patient risk factors for SSI 
when considering potential candidates for prophylaxis, however the low power of the studies 
involved highlights the need for larger and adequately powered studies in this field. We hope 
that the results of this study will encourage further research regarding risk factors for SSI, to 
contribute to clinical practice guidelines regarding antibiotic prophylaxis, ideally leading to 
more judicious and evidence based antibiotic prescription. 
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Tables  
Table 1. ‘PICO’ search strategy. 
‘PICO’ terms Description 
Population All patients undergoing a minor dermatological surgical procedure 
worldwide (1990-onwards) 
 
Intervention The presence of a risk factor which increase or decreases the 
likelihood of developing a surgical site infection, including but not 
limited to  
- Age >65 
- Tobacco smoking  
- Diabetes mellitus/other medical comorbidities 
- Wound size  
- Wound location 
- Complexity of surgery  
- Use of corticosteroids 
- Use of immunomodulatory drugs 
 
Comparison Absence of the risk factor in that same population  
 
Outcome Primary 
- Surgical site infection  
Secondary 
- Scarring/cosmesis 
- Cellulitis, deeper infection, sepsis 
- Death 
- Length of stay  
 



















All patients receiving surgical procedures in the study period 
(2002-2003) by the volunteer members of the dermatological 
surgical society. Non-exposed/exposed arising from same 
community. Source of ascertainment of exposure not described. 
Demonstrated outcome was not present before starting study by 






analysis.   
Outcome based on self-reported 
subjective/objective classification. Follow-
up period not specified, but appeared to 
capture outcome specified in all cases. No 






clinic rooms  
Prospective 
cohort  
All patients presenting to a dermatology clinic (2006-2007). Non-
exposed/exposed arising from same community. Ascertainment 
of exposure from either structured questionnaire or secure record. 






analysis (but not 
for infection 
outcome)   
Outcome objectively and blindly confirmed 
by pathologist (cultures required to confirm 
infection). Did not specify period of follow-
up, although suture removal was used as a 
marker, and follow-up prompted by 











All patients managed at a private clinic (2002-2005) by one 
surgeon. Non-exposed/exposed arising from same community. 
Source of ascertainment of exposure not described but 
presumably from patient, staff and self-reporting. Avoided 
Not controlled for 
variables, did not 
perform 
multivariate 
analysis.   
Outcome assessed subjectively through 
predetermined categories. Not specified who 
assessed but likely self-reported. Strong 





including those with outcome before study by excluding those 
who had the outcome until they were treated.  
suture removal, appropriate for outcome. No 




Day surgery theatre 




All patients from 23 hospitals (2004-2005) undergoing plastic 
and reconstructive surgery. Non-exposed/exposed arising from 
same community.  Source of ascertainment of exposure not 
described. Did not demonstrate that outcome was not present 






analysis.   
Outcome assessed using a standardised 
criterion (CDC), not specified whether this 
was blinded. Appropriate follow-up period 
of entire hospital stay or 30 days post 








surgery room  
Retrospective 
chart review 
Random patients from a surgical logbook obtained 
chronologically. Non-exposed/exposed arising from same 
community.  Ascertained exposure from medical records, and 
patients if information was missing. Did not demonstrate that 
outcome was not present before study. 
Not controlled for 





Outcome assessed subjectively using 
clinical features or objectively based on a 
clinician’s decision to prescribe antibiotics. 
Did not specify who made this assessment 






Setting not specified 
Prospective 
cohort 
All outpatients receiving plastic surgery (1995-1996). Non-
exposed/exposed arising from same community.  Source of 
ascertainment of exposure not described. Partially avoided 
including those with outcome before study by excluding those 
with abnormal blood results. Infection is often present without 







Outcome assessed subjectively by medical 
staff at varying time intervals, using clinical 
features. Follow-up intervals appropriate to 













in a trial  
All patients presenting for minor skin excisions at four general 
practices (2004-2005), invited to participate in a trial, performed 
by 19 general practitioners. Non-exposed/exposed arising from 





Outcome assessed with a standardised 
criterion (CDC) by a nurse/doctor who was 
not an investigator. Follow-up period was 
until suture removal, appropriate for the 
High 
medical records from practice nurses. Demonstrated outcome 
was not present prior to study via exclusion criteria. 
multivariate 
analysis. 







skin cancer clinic 





in a trial 
All patients presenting for minor skin excisions at three general 
practices, invited to participate in a trial, performed by 16 general 
practitioners. Non-exposed/exposed arising from same 
community. Ascertained exposure from general practice medical 
records from practice nurses. Demonstrated outcome was not 







Outcome assessed with a standardised 
criterion (CDC) by a nurse/doctor who was 
not an investigator. Follow-up period was 
until suture removal, appropriate for the 










All consecutive patients receiving skin excisions by a single 
surgeon at a private hospital. Non-exposed/exposed arising from 
same community. Ascertained exposure from a standardised data 
collection form. Did not demonstrate that outcome was not 







Outcome assessed by surgeon subjectively, 
self-reported by patient, or objectively 
based on antibiotic prescription. Follow-up 















All patients receiving surgical procedures in the study period 
(2002-2003) by the volunteer members of the dermatological 
surgical society. Non-exposed/exposed arising from same 
community. Source of ascertainment of exposure not described. 
Demonstrated outcome was not present before starting study by 






Not specified who assessed outcome, but 
this was done by a non-reported 
classification procedure. Follow-up period 










Patients who had received resection of skin tumours around the 
head and neck area. Non-exposed/exposed arising from same 




Did not specific how outcome was assessed 
or by whom. Did not specify follow-up 
period. No patients lost to follow up.  
Low 
community. Source of ascertainment of exposure not described. 
Did not demonstrate that outcome was not present before study. 
with multivariate 
analysis. 






All patients attending plastic surgical unit (1995-1995) for 
clean elective facial surgery. Non-exposed/exposed arising 
from same community. Ascertained exposure from a 
standardised questionnaire. Demonstrated outcome was not 
present before starting study by excluding those with suspected 
outcome. 





Outcome assessed blindly but subjectively 
by non-investigating clinicians. Graded 
outcome based on a surrogate criterion. 
Objectively classified on a pathological 
basis.   
Low  







All patients who underwent incisional and excision skin 
biopsies during admission in a 9-month period in 2006. Non-
exposed/exposed arising from same community. Exposure data 
ascertained by records, notes, microbiology reports and charts. 






analysis.  but none 
found. Low 
positive events (29) 
Outcome assessed by investigator, 
subjectively using clinical features. Follow -
up was until discharge, appropriate for 




Table 3. Risk factors for surgical site infection in dermatological surgery. a Presented as 
relative risk (RR), odds ratio (OR) or proportions of the exposed vs. unexposed populations 
with infection. 1No significant risk factors were found on univariate analysis. When looking at 
surgical site alone in logistic regression, the mentioned locations were found to be significantly 
associated with increased infection. 2Odds ratios were not presented for variables which had 
more than one category; proportions presented for these variables. p Indicates a sample size of 
procedures/excisions rather than the number of patients. 3 Univariate results presented as no 
significant risk factors came out of multivariate analysis. Likely due to small sample size and 
number of infections. 95% confidence intervals are for the difference in measures. All studies 
which present confidence intervals conducted multivariate analysis. COPD – chronic 




















































Skin grafts  
 






















Preoperative radiotherapy  
 
























Involvement of cartilage 
 
Mohs surgery on ear v non-ear 
28.5% v 5.9% 
 
12.5% v 1.45%  
Not provided 
 





Older age (>50 years) 
 








































































































Lower limb (17.6%) 
 





















Male gender  
 






























Defect larger than median v 
defect smaller than median 
7.5% v 1.4% 
 
Not specified  
(p=0.01) 
(Germany)  










Oncological surgery v non-
oncological surgery 
 































Below waist v above waist 
 
In ward v in operating theatre 
 
Senior house officer v specialist 
registrar & consultant 
 
Smoker v non-smoker 
 
Corticosteroids v none 
48% v 23% 
 
53% v 17% 
 
33% v 14% 
 
 
64% v 12% 
 
63% v 21% 
4%-47% 
(p=0.02) 
17%-55% 
(p<0.001) 
2%-37% 
(p=0.03) 
 
34%-70% 
(p<0.001) 
19%-66% 
(p<0.001) 
 
 
 
 
